CFO transition
Credit Acceptance Corporation CFO transition: Joseph Billante to succeed Jay D. Martin
Credit Acceptance Corporation reported in a Form 8-K filed June 10, 2026 that Joseph Billante will succeed Jay D. Martin as Chief Financial Officer, effective July 27, 2026.
In the filing's words
On June 8, 2026, the board of directors of the Company (the “Board”) elected and appointed Joseph Billante to succeed Mr. Martin as the Company’s Chief Financial Officer effective July 27, 2026. In his capacity as Chief Financial Officer, Mr. Billante will be the Company’s principal financial officer and principal accounting officer.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Credit Acceptance Corporation (CACC) |
|---|---|
| Event | Transition |
| Incoming | Joseph Billante |
| Outgoing | Jay D. Martin |
| Title in the filing | Chief Financial Officer |
| Effective | July 27, 2026 |
| 8-K filed | June 10, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Chief Financial Officer, Barracuda Networks, Inc. |
| SEC CIK | 0000885550 |
Credit Acceptance Corporation reported this change in a Form 8-K, Item 5.02, filed June 10, 2026. The filing's own words are quoted above.
Other records naming Jay D. Martin
1The outgoing officer on this record, matched by name. Career line.
2026-02-13 · 10-K signature
Jay D. Martin signed Credit Acceptance Corporation's annual report as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Joseph Billante? Send a correction with the primary source.